News & Updates

Single-nucleotide variants linked to doxorubicin pharmacokinetics

01 Nov 2023

Several factors are directly associated with either an increase or a decrease of pharmacokinetic parameters of doxorubicin, reports a recent study.

Single-nucleotide variants linked to doxorubicin pharmacokinetics

01 Nov 2023

What are the risk factors for severe actinic keratosis?

31 Oct 2023

Older age, lower skin phototype classifications, and a personal history of skin cancer may influence the severity of actinic keratosis (AK), while the use of calcium channel blockers (CCBs) is linked to more severe AK, as reported in a study.

What are the risk factors for severe actinic keratosis?

31 Oct 2023

Esketamine outperforms quetiapine in head-to-head depression trial

30 Oct 2023 by

In patients with treatment-resistant depression, esketamine nasal spray appears to have superior efficacy compared with extended-release quetiapine when used in combination with conventional antidepressants.

Esketamine outperforms quetiapine in head-to-head depression trial

30 Oct 2023

Podcast: Professor Flor Munoz discusses the importance of vaccination for pregnant women and children against COVID-19 at IDWeek 2023

30 Oct 2023

Podcast: Professor Flor Munoz discusses the importance of vaccination for pregnant women and children against COVID-19 at IDWeek 2023

30 Oct 2023

Semaglutide benefits held up for 3 years

30 Oct 2023 by

Once weekly treatment with the glucagon-like peptide 1 receptor agonist (GLP-1 RA) semaglutide significantly reduced HbA_1c level and body weight in a large cohort of adults with type 2 diabetes (T2D) in a real-world study from Israel.

Semaglutide benefits held up for 3 years

30 Oct 2023

Antiviral therapy safe, effective in children with immune-tolerant HBV infection

28 Oct 2023

Treatment with antiviral therapy is beneficial and generally tolerated in children with chronic hepatitis B virus (HBV) infection in the immune-tolerant stage, according to the results of a systematic review and meta-analysis.

Antiviral therapy safe, effective in children with immune-tolerant HBV infection

28 Oct 2023

Oral herbal supplement bests estrogen plus progestogen therapy for menopausal symptoms

27 Oct 2023

Use of an oral herbal supplement appears to be more favourable than oestrogen plus progestogen therapy in terms of reducing global, physical, and psychosocial menopausal symptoms in the short term, according to a phase II study.

Oral herbal supplement bests estrogen plus progestogen therapy for menopausal symptoms

27 Oct 2023

Canagliflozin holds promise against MAFLD in T2D patients

27 Oct 2023 by

Patients with type 2 diabetes (T2D) who received canagliflozin benefit from improved liver biochemistry and metabolism, a recent study has shown. In addition, treatment with canagliflozin appears to confer positive effects on liver fibrosis.

Canagliflozin holds promise against MAFLD in T2D patients

27 Oct 2023

Ivarmacitinib efficacious, well tolerated in moderate-to-severe alopecia areata

27 Oct 2023

Use of ivarmacitinib 4- and 8-mg doses for 24 weeks eases hair loss and is generally tolerated in patients with moderate or severe alopecia areata (AA), a phase II study has shown.

Ivarmacitinib efficacious, well tolerated in moderate-to-severe alopecia areata

27 Oct 2023

4-hydroxytamoxifen gel strikes out in ductal carcinoma in situ lesions

27 Oct 2023

Local transdermal therapy with 4-hydroxytamoxifen appears to be less effective than full-dose oral tamoxifen in terms of suppressing proliferation in ductal carcinoma in situ lesions for breast cancer prevention, according to a phase II study.

4-hydroxytamoxifen gel strikes out in ductal carcinoma in situ lesions

27 Oct 2023

News & Updates

Filter by Specialty:

Specialty:

Single-nucleotide variants linked to doxorubicin pharmacokinetics

Single-nucleotide variants linked to doxorubicin pharmacokinetics

What are the risk factors for severe actinic keratosis?

What are the risk factors for severe actinic keratosis?

Esketamine outperforms quetiapine in head-to-head depression trial

Esketamine outperforms quetiapine in head-to-head depression trial

Podcast: Professor Flor Munoz discusses the importance of vaccination for pregnant women and children against COVID-19 at IDWeek 2023

Podcast: Professor Flor Munoz discusses the importance of vaccination for pregnant women and children against COVID-19 at IDWeek 2023

Semaglutide benefits held up for 3 years

Semaglutide benefits held up for 3 years

Antiviral therapy safe, effective in children with immune-tolerant HBV infection

Antiviral therapy safe, effective in children with immune-tolerant HBV infection

Oral herbal supplement bests estrogen plus progestogen therapy for menopausal symptoms

Oral herbal supplement bests estrogen plus progestogen therapy for menopausal symptoms

Canagliflozin holds promise against MAFLD in T2D patients

Canagliflozin holds promise against MAFLD in T2D patients

Ivarmacitinib efficacious, well tolerated in moderate-to-severe alopecia areata

Ivarmacitinib efficacious, well tolerated in moderate-to-severe alopecia areata

4-hydroxytamoxifen gel strikes out in ductal carcinoma in situ lesions

4-hydroxytamoxifen gel strikes out in ductal carcinoma in situ lesions